Current state of diagnostic technologies in the autoimmunology laboratory

Clinical Chemistry and Laboratory Medicine

Volumn 51, Issue 1, 2013, Pages 129-138

  Tozzoli, Renato ^b   Bonaguri, Chiara ^c   Melegari, Alessandra ^d   Antico, Antonio ^e   Bassetti, Danila ^f   Bizzaro, Nicola ^a  

^a Ospedale S Antonio   (Italy)

^b S MARIA DEGLI ANGELI HOSPITAL   (Italy)

^c Azienda Ospedaliera Universitaria   (Italy)

^d Nuovo Ospedale S Agostino   (Italy)

^e Ospedale Civile   (Italy)

^f SANTA CHIARA HOSPITAL   (Italy)

Author keywords

Autoimmune diseases; Automation; Indirect immunofluorescence; Monoplex and multiplex immunoassay methods; Standardization

Indexed keywords

AUTOANTIBODY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AUTOIMMUNE DISEASE; AUTOIMMUNITY; DIAGNOSTIC PROCEDURE; HUMAN; IMMUNOASSAY; IMMUNOFLUORESCENCE; IMMUNOMETRIC ASSAY; LABORATORY TEST; PRIORITY JOURNAL; REVIEW;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNITY; DIAGNOSTIC TECHNIQUES AND PROCEDURES; HUMANS; IMMUNOLOGIC TECHNIQUES; LABORATORIES;

MONOPLEX;

EID: 84872977598     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2012-0191     Document Type: Review

References (95)

1. Tozzoli R. Recent advances in diagnostic technologies and their impact in autoimmune diseases. Autoimmun Rev 2007;6:334-40.
2. Hargraves MM, Richmond H, Morton R. Presentation of two bone marrow elements: the tart cell and the L.E. cell. Mayo Clin Proc 1948;23:25-8.
3. Friou GJ. Clinical application of lupus serum-nucleoprotein reaction using fluorescent antibody technique. J Clin Invest 1957;86:890-6.
4. Holborow EJ, Weir DM, Johnson GD. A serum factor in lupus erythematosus with affinity for tissue nuclei. Br Med J 1957;2:732-4.
5. Wiik A, Hoier-Madsen M, Forslid J, Charles P, Meyrowitsch J. Antinuclear antibodies: a contemporary nomenclature using HEp-2 cells. J Autoimmun 2010;35:276-90.
6. Robbins WC, Holman HR, Deicher H, Kunkel HG. Complement fixation with all nuclei and DNA in lupus erythematosus. Proc Soc Exp Biol Med 1957;96:575-9.
7. Trotter WR, Belyavin G, Waddams A. Precipitating and complement-fixing antibodies in Hashimoto ' s disease. Proc Roy Soc Med 1957;50:961-2.
8. Anderson JD, Goudie RB, Gray K. Autoantibodies in Addison ' s disease. Lancet 1957;1:1123-4.
9. Witebsky E, Rose NR, Teplan K. Chronic thyroiditis and immunization. J Am Med Assoc 1957;64:1439-43.
10. Ceppellini R, Polli E, Celada F. A DNA-reacting factor in serum of a patient with lupus erythematosus diffusus. Proc Soc Exp Biol Med 1957;96:572-4.
11. Doniach D, Roitt IM. Auto-immunity in Hashimoto ' s disease and its implications. J Clin Endocrinol Metab 1957;17:1293-304.
12. Tozzoli R, Bizzaro N. The clinical autoimmunologist and the laboratory autoimmunologist: the two sides of the coin. Autoimmun Rev 2012, doi:10-1016/J autrev.2012.02.011.
13. Ellington AA, Kullo IJ, Bailey KR, Klee GG. Antibody-based protein multiplex platforms. Technical and operational challenges. Clin Chem 2010;56:186-93.
14. Robinson WH, Steinman L, Utz PJ. Proteomic technologies for the study of autoimmune disease. Arthritis Rheum 2002;46:885-93.
15. Wu T, Mohan C. Proteomic toolbox for autoimmunity research. Autoimmun Rev 2009;8:595-8.
16. Fritzler MJ. Advances and applications of multiplexed diagnostic technologies in autoimmune diseases. Lupus 2006;15:422-7.
17. Tozzoli R, Bizzaro N. Novel diagnostic methods for autoantibody detection. In: Shoenfeld Y, Gershwin ME, Meroni PL, editors. Autoantibodies. Amsterdam: Elsevier, 2006:77-82.
18. Bizzaro N, Tozzoli R, Shoenfeld Y. Are we at a stage to predict autoimmune rheumatic diseases? Arthritis Rheum 2007;56:1736-44.
19. Ekins R, Chu F. Multianalyte microspot immunoassay: the microanalytical compact disk of the future. Ann Biol Clin (Paris) 1992;50:337-53.
20. Robinson WH, DiGennaro C, Hueber W, Haab BB, Kamachi M, Dean EJ, et al. Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat Med 2002;8: 295-301.
21. Hueber W, Kidd BA, Tomooka BH, Lee BJ, Bruce B, Fries JF, et al. Antigen microarray profiling of autoantibodies in rheumatoid arthritis. Arthritis Rheum 2005;52:2645-55.
22. McBride JD, Gabriel FG, Fordham J, Kolind T, Barcenas-Morales G, Isenberg DA, et al. Screening autoantibody profiles in systemic rheumatic disease with a diagnostic protein microarray that use a filtration assisted nanodot array luminometric immunoassay (NALIA). Clin Chem 2008;54:883-90.
23. Meheus L, van Venrooij WJ, Wiik A, Charles PJ, Tzioufas AG, Meyer O, et al. Multicenter validation of recombinant, natural and synthetic antigens used in a single multiparameter assay for the detection of specific anti-nuclear autoantibodies in connective tissue disorders. Clin Exp Rheumatol 1999;17: 205-14.
24. Lopez-Longo FJ, Rodriguez-Mahou M, Escalona-Monge M, González CM, Monteagudo I, Carreño-Pérez L. Simultaneous identification of various antinuclear antibodies using an automated multiparameter line immunoassay system. Lupus 2003;12:623-9.
25. Pottel H, Wiik A, Locht H, Gordon T, Roberts-Thomson P, Abraham D, et al. Clinical optimization and multicenter validation of antigen-specific cut-off values on the INNO-LIA ANA update for the detection of autoantibodies in connective tissue disorders. Clin Exp Rheumatol 2004;22:579-88.
26. Eissfeller P, Sticherling M, Scholz D, Hennig K, Luttich T, Motz M, et al. Comparison of different test systems for simultaneous antoantibody detection in connective tissue diseases. Ann N Y Acad Sci 2005;1050:327-39.
27. Almeida Gonzalez D, Cabrera de Leon A, Rodriguez Perez MdelC, Brito Díaz B, González Hernández A, García García D, et al. Efficiency of different strategies to detect autoantibodies to extractable nuclear antigens. J Immunol Methods 2010;360:89-95.
28. Bizzaro N, Bonelli F, Tonutti E, Villalta D, Tozzoli R. New coupledparticle light-scattering assay for detection of Ro/SSA (52 and 60 kilodaltons) and La/SSB autoantibodies in connective tissue diseases. Clin Diagn Lab Immunol 2001;8:922-5.
29. Fulton RJ, McDade RL, Smith PL, Kienker LJ, Kettman JR Jr. Advanced multiplexed analysis with the FluoMetrix system. Clin Chem 1997;43:1749-56.
30. Rouquette A-M, Desgruelles C, Laroche P. Evaluation of the new multiplexed immunoassay, FIDIS, for simultaneous quantitative determination of antinuclear antibodies and comparison with conventional methods. Am J Clin Pathol 2003;120:676-81.
31. Yiannaki E, Zintzaras E, Analatos A, Thedoridou C, Dalekos GN, Germenis AE. Evaluation of a microsphere-based flow cytometric assay for diagnosis of celiac disease. J Immunoassay Immunochem 2004;25:345-7.
32. Abreu I, Laroche P, Bastos A, Issert V, Cruz M, Nero P, et al. Multiplexed immunoassay for detection of rheumatoid factors by FIDISTM technology. Ann N Y Acad Sci 2005;1050:357-63.
33. Tozzoli R, Villalta D, Kodermaz G, Bagnasco M, Tonutti E, Bizzaro N. Autoantibody profiling of patients with autoimmune thyroid disease using a new multiplexed immunoassay method. Clin Chem Lab Med 2006;44:837-42.
34. Gonzalez C, Garcia-Berrocal B, Talavan T, Casas ML, Navajo JA, Gonzalez-Buitrago JM. Clinical evaluation of a microsphere bead-based flow cytometry assay for the simultaneous determination of anti-thyroid peroxidase and anti-thyroglobulin antibodies. Clin Biochem 2005;38:966-72.
35. Damoiseaux J, Vaessen M, Knapen Y, Csernok E, Stegeman CA, Van Paassen P, et al. Evaluation of the FIDIS vasculitis multiplex immunoassay for diagnosis and follow-up of ANCA-associated vasculitis and Goodpasture ' s disease. Ann N Y Acad Sci 2007;1109:454-63.
36. Copple SS, Martins TB, Masterson C, Joly E, Hill HR. Comparison of three multiplex immunoassays for detection of antibodies to extractable nuclear antibodies using clinically defined sera. Ann N Y Acad Sci 2007;1109:464-72.
37. Albon S, Bunn C, Swana G, Karim Y. Performance of a multiplex assay compared to enzyme and precipitation methods for anti-ENA testing in systemic lupus and systemic sclerosis. J Immunol Methods 2011;365:126-31.
38. Gilburd B, Abu-Shakra M, Shoenfeld Y, Giordano A, Bocci EB, delle Monache F, et al. Autoantibodies profile in the sera of patients with Sjögren syndrome: the ANA evaluation - a homogeneous, multiplexed system. Clin Dev Immunol 2004;11:53-6.
39. Shovman O, Gilburd B, Zandman-Goddard G, Yehiely A, Langevitz P, Shoenfeld Y. Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases. Autoimmunity 2005;38:105-9.
40. Zandman-Goddard G, Gilburd B, Shovman O, Blank M, Berdichevski S, Langevitz P, et al. The homogeneous multiplexed system - a new method for autoantibody profile in systemic lupus erythemathosus. Clin Dev Immunol 2005;12:107-11.
41. Nifli A-P, Notas G, Mamoulaki M, Niniraki M, Ampartzaki V, Theodoropoulos PA, et al. Comparison of a multiplex, bead-based fluorescent assay and immunofluorescence methods for the detection of ANA and ANCA autoantibodies in human serum. J Immunol Methods 2006;311:189-97.
42. Bonilla E, Francis L, Allam F, Ogrinc M, Neupane H, Phillips PE, et al. Immunofluorescence microscopy is superior to fluorescent beads for detection of antinuclear antibody reactivity in systemic lupus erythematosus patients. Clin Immunol 2007;124:18-21.
43. Caramaschi P, Ruzzenente O, Pieropan S, Volpe A, Carletto A, Bambara LM, et al. Determination of ANA specificity using multiplexed fluorescent microsphere immunoassay in patients with ANA positivity at high titres after infliximab treatment: preliminary results. Rheumatol Int 2007;27:649-54.
44. Avaniss-Aghajani E, Berzon S, Sarkissian A. Clinical value of multiplexed bead-based immunoassays for detection of autoantibodies to nuclear antigens. Clin Vaccine Immunol 2007;14:505-9.
45. Biagini RE, Parks CG, Smith JP, Sammons DL, Robertson SA. Analytical performance of the AtheNA Multilite ANA II assay in sera from lupus patients with multiple positive ANAs. Anal Bioanal Chem 2007;388:613-8.
46. Salamunic I, Paukovic-Sekulic B, Galetovic A. Comparative analysis of multiplex AtheNA multi-lyte ANA test system and conventional laboratory methods to detect autoantibodies. Biochemia Medica 2008;18:88-98.
47. Eriksson C, Kokkonen H, Johansson M, Hallmans G, Wadell G, Rantapää-Dahlqvist S. Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden. Arthritis Res Ther 2011:13:R30.
48. Giovanella L, Toffalori E, Tozzoli R, Caputo M, Ceriani L, Verburg FA. Multiplexed immunoassay of thyroglobulin autoantibodies in patients with differentiated thyroid carcinoma. Head Neck 2011. doi:10.1002/hed 21933.
49. Martins TB, Burlingame R, von Muhlen C, Jaskowski TD, Litwin CM, Hill HR. Evaluation of multiplexed fluorescent microsphere immunoassay for detection of autoantibodies to nuclear antigens. Clin Diagn Lab Immunol 2004;11:1054-9.
50. Mahler M, Stinton LM, Fritzler MJ. Improved serological differentiation between systemic lupus erythematosus and mixed connective tissue disease by use of an SmD3 peptide-based immunoassay. Clin Diagn Lab Immunol 2005;12:107-13.
51. Fritzler MJ, Behmanesh F, Fritzler ML. Analysis of human sera that are polyreactive in an addressable laser bead immunoassay. Clin Immunol 2006;120:349-56.
52. Hanly JG, Su L, Farewell V, Fritzler MJ. Comparison between multiplex assays for autoantoantibody detection in systemic lupus erythematosus. J Immunol Methods 2010;358:75-80.
53. Shovman O, Gilburd B, Barzilai O, Shinar E, Larida D, Zandman- Goddard G, et al. Evaluation of the BioPlex 2200 ANA screen: analysis of 510 healthy subjects: incidence of natural/predictive autoantibodies. Ann N Y Acad Sci 2005;1050:380-8.
54. Binder SR, Genovese MC, Merrill JT, Morris RI, Metzger AL. Computer-assisted pattern recognition of autoantibody results. Clin Diagn Lab Immunol 2005;12:1353-7.
55. Moder KG, Wener MH, Weisman MH, Ishimori ML, Wallace DJ, Buckeridge DL, et al. Measurement of antinuclear antibodies by multiplex immunoassay: a prospective, multicenter clinical evaluation. J Rheumatol 2007;34:978-86.
56. Desplat-Jego S, Bardin N, Larida B, Sanmarco M. Evaluation of the BioPlex 2200 ANA screen for the detection of antinuclear antibodies and comparison with conventional methods. Ann N Y Acad Sci 2007;1109:245-55.
57. Tozzoli R, Barzilai O, Ram M, Villalta D, Bizzaro N, Sherer Y, et al. Infections and autoimmune thyroid diseases: parallel detection of antibodies against pathogens with proteomic technology. Autoimmun Rev 2008;8:112-5.
58. Kaul R, Johnson K, Scholz H, Marr G. Performance of the BioPlex 2200 autoimmune vasculitis kit. Autoimmun Rev 2009;8:224-7.
59. Bardin N, Desplat-Jego S, Daniel L, Jourde Chiche N, Sanmarco M. BioPlex 2200 multiplexed system: simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus. Autoimmunity 2009;42:63-8.
60. Orbach H, Amitai N, Barzilai O, Boaz M, Ram M, Zandman- Goddard G, et al. Autoantibody screen in inflammatory myopathies: high prevalence of antibodies to gliadin. Ann N Y Acad Sci 2009;1173:174-9.
61. Lidar M, Langevitz P, Barzilai O, Ram M, Porat-Katz BS, Bizzaro N, et al. Infectious serologies and autoantibodies in inflammatory bowel disease: insinuations at a true pathogenic role. Ann N Y Acad Sci 2009;1173:640-8.
62. Hanly JG, Thompson K, McCurdy G, Fougere L, Theriault C, Wilton K. Measurement of autoantibodies using multiplex methodology in patients with systemic lupus erythematosus. J Immunol Methods 2010;352:147-52.
63. Shapira Y, Poratkatz BS, Gilburd B, Barzilai O, Ram M, Blank M, et al. Geographical differences in autoantibodies and anti-infectious agents antibodies among healthy adults. Clin Rev Allergy Immunol 2012;42:154-63.
64. Kim Y, Park Y, Lee EY, Kim HS. Comparison of automated multiplexed bead-based ANA screening assay with ELISA for detecting five common anti-extractable nuclear antigens and anti-dsDNA in systemic rheumatic diseases. Clin Chim Acta 2012;413:308-11.
65. Op De Beeck K, Vermeesch P, Verschueren P, Westhovens R, Marien G, Blockmans D, et al. Antinuclear antibody detection by automated multiplex immunoassay in untreated patients at the time of diagnosis. Autoimmun Rev 2012 (Epub ahead of print).
66. Tozzoli R. The diagnostic role of autoantibodies in the prediction of organ specific autoimmune diseases. Clin Chem Lab Med 2008;46:577-87.
67. Solomon DH, Kavanaugh AJ, Schur PH. Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum 2002;47:434-44.
68. Tozzoli R, Bizzaro N, Tonutti E, Villalta D, Bassetti D, Manoni F, et al. Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases. Am J Clin Pathol 2002;117:316-24.
69. Meroni PL, Schur PH. ANA screening: an old test with new recommendations. Ann Rheum Dis 2010;69:1420-2.
70. Savige JF, Gillis DF, Benson E, Davies D, Esnault V, Falk RJ, et al. International Consensus Statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA). Am J Clin Pathol 1999;111:507-13.
71. Rigon A, Soda P, Zennaro D, Iannello G, Afeltra A. Indirect immunofluorescence in autoimmune diseases: assessment of digital images for diagnostic purpose. Cytometry B 2007;72B:472-7.
72. Fritzler MJ. The antinuclear antibody test: last or lasting gasp? Arthritis Rheum 2011;63:19-22.
73. Jaskowski TD, Schroder C, Martins TB, Mouritsen CL, Litwin CM, Hill HR. Screening of antinuclear antibodies by enzyme immunoassay. Am J Clin Pathol 1996;105:468-73.
74. Emlen W, O ' Neill L. Clinical significance of antinuclear antibodies. Arthritis Rheum 1997;40:1612-8.
75. Gniewek RA, Stites DP, McHugh TM, Hilton JF, Nakagawa M. Comparison of antinuclear antibody testing: immunofluorescence assay versus enzyme immunoassay. Clin Diagn Lab Immunol 1997;4:185-8.
76. Homburger HA, Cahen YD, Griffiths J, Jacob GL. Detection of antinuclear antibodies: comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods. Arch Pathol Lab Med 1998;122:993-9.
77. Rondeel JM, van Gelder W, van der Leeden H, Dinkelaar RB. Different strategies in the laboratory diagnosis of autoimmune disease: immunofluorescence, enzyme-linked immunosorbent assay or both? Ann Clin Biochem 1999;36:189-95.
78. Olaussen E, Rekvig OP. Screening tests for antinuclear antibodies: selective use of central nuclear antigens as a rational basis for screening by ELISA. J Autoimmun 1999;13: 95-102.
79. Ulvestad E. Performance characteristics and clinical utility of a hybrid ELISA for detection of ANA. APMIS 2001;109:217-22.
80. Bernardini S, Infantino M, Bellicampi L, Nuccetelli M, Afeltra A, Lori R, et al. Screening of antinuclear antibodies: comparison between enzyme immunoassay based on nuclear homogenates, purified or recombinant antigens and immunofluorescence assay. Clin Chem Lab Med 2004;42:1155-60.
81. Tonutti E, Bassetti D, Piazza A, Visentini D, Poletto M, Bassetto F, et al. Diagnostic accuracy of ELISA methods as an alternative screening test to indirect immunofluorescence for the detection of antinuclear antibodies. Evaluation of five commercial kits. Autoimmunity 2004;37:171-6.
82. Fenger M, Wiik A, Hoier-Madsen M, Lykkegaard JJ, Rozenfeld T, Hansen MS, et al. Detection of antinuclear antibodies by solid-phase immunoassays and immunofluorescence analysis. Clin Chem 2004;50:2141-7.
83. Sinclair D, Saas M, Williams D, Hart M, Goswami R. Can an ELISA replace immunofluorescence for the detection of anti-nuclear antibodies? The routine use of anti-nuclear antibody screening ELISAs. Clin Lab 2007;53:183-91.
84. Lopez-Hoyos M, Rodriguez-Valverde V, Martinez-Taboada V. Performance of antinuclear antibody connective tissue disease screen. Ann N Y Acad Sci 2007;1109:322-9.
85. Hayashi N, Kawamoto T, Mukai M, Morinobu A, Koshiba M, Kondo S, et al. Detection of antinuclear antibodies by use of an enzyme immunoassay with nuclear HEp-2 cell extract and recombinant antigens: comparison with immunofluorescence assay in 307 patients. Clin Chem 2001;47:1649-59.
86. Gonzalez C, Garcia-Berrocal B, Perez J, Navajo JA, Herraez O, Gonzá lez-Buitrago JM. Laboratory screening of connective tissue diseases by a new automated ENA screening assay (EliA Symphony) in clinically defined patients. Clin Chim Acta 2005;359:109-14.
87. Ghillani P, Rouquette AM, Desgruelles C, Hauguel N, Le Pendeven C, Piette JC, et al. Evaluation of the LIAISON ANA screen assay for antinuclear antibody testing in autoimmune diseases. Ann N Y Acad Sci 2007;1109:407-13.
88. Hu Y, Murphy RF. Automated interpretation of subcellular patterns from immunofluorescence microscopy. J Immunol Methods 2004;290:93-105.
89. Glory EM, Murphy RF. Automated subcellular location determination and high throughput microscopy. Dev Cell 2007;12:7-16.
90. Hiemann R, Buttner T, Krieger T, Roggenbuck D, Sack U, Conrad K. Challenges of automated screening and differentiation of non-organ specific autoantibodies on HEp-2 cells. Autoimmun Rev 2009;9:17-22.
91. Egerer K, Roggenbuck D, Hiemann R, Weyer MG, Büttner T, Radau B, et al. Automated evaluation of autoantibodies on human epithelial-2 cells as an approach to standardize cell-based immunofluorescence tests. Arthritis Res Ther 2010;12:R40.
92. Rigon A, Buzzulini F, Soda P, Onofri L, Arcarese L, Iannello G, et al. Novel opportunities in automated classification of antinuclear antibodies on HEp-2 cells. Autoimmun Rev 2011;10:647-52.
93. Kivity S, Gilburd B, Agmon-Levin N, Garcia Carrasco M, Tzafrir Y, Sofer Y, et al. A novel automated indirect immunofluorescence autoantibody evaluation. Clin Rheumatol 2012;31:503-9.
94. Melegari A, Bonaguri C, Russo A, Luisita B, Trenti T, Lippi G. A comparative study on the reliability of an automated system for the evaluation of cell-based indirect immunofluorescence. Autoimmun Rev 2012. Epub ahead of print. doi:10.1016/j.autrev.2011.12.010.
95. Mariz H, Sato E, Barbosa SH, Rodrigues SH, Dellavance A, Andrade LE. Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibodypositive healthy individuals and patients with autoimmune rheumatic diseases. ArthritisRheum 2011;63:191-200.